Suppr超能文献

替米沙坦和雷米普利对伴有肾病的 1 型糖尿病患者 24 小时血压谱和杓型模式影响的初步研究。

A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy.

机构信息

Department of Endocrinology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

出版信息

Indian J Med Res. 2011 Nov;134(5):658-63. doi: 10.4103/0971-5916.90991.

Abstract

BACKGROUND & OBJECTIVES: Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) have been used to normalize the blood pressure and the dipping pattern in patients with type 1 diabetes mellitus (T1DM) and nephropathy. However, there are no data on the effect of the dual blockade on the dipping pattern in these subjects. We therefore, carried out this study to evaluate the effect of administrating an ACEI followed by ARB in the optimum doses in T1DM patients with nephropathy on 24 h blood pressure (BP) profile and nocturnal dipping pattern.

METHODS

An open label interventional pilot study was done during a one year period involving 30 consecutive patients who were treated with telmisartan 80 mg (0800-1000 h) for eight weeks followed by addition of ramipril 10 mg (1200-1400 h) for the next eight weeks. Ambulatory BP, dipping pattern and albumin excretion rate were studied after each phase. Twenty patients were hypertensive and 10 patients had macro- and 20 patients had microalbuminuria.

RESULTS

Telmisartan produced a fall in the clinic BP by 4/1.3 mm Hg (P<0.05 and P<0.362, respectively), 2/1.9 mm Hg in the mean 24 h BP, 1.4/1.1 mm Hg in the day BP and 3.7/3 mm Hg in the trough BP. Addition of ramipril to telmisartan produced a further reduction of 6.3/5.9 mm Hg in the clinic BP (P<0.001 for both), 4.3/4.2 mm Hg in the mean 24 h BP (P<0.01 and P<0.0001, respectively), 5.8/3.9 mm Hg in the day BP (P<0.01 for both), 4.2/2.5 mm Hg in the trough BP, with a reduction of clinic SBP and DBP of 10.3/7.2 mm Hg from the baseline. Telmisartan restored normal systolic dipping pattern in 33.3 per cent of the nondippers (P<0.01) but addition of ramipril was not complimentary. Hyperkalamia (>5.5 mmol/l) was observed only in 2 patients towards the end of the study.

INTERPRETATION & CONCLUSIONS: The dual blockade with telmisartan and ramipril had complimentary effect on lowering of the BP, however, similar beneficial effect on the nocturnal dipping was not observed. Further studies with large number of subjects with longer duration of follow-up are required to validate these observations.

摘要

背景与目的

血管紧张素转换酶抑制剂(ACEI)或血管紧张素受体阻滞剂(ARB)已被用于使 1 型糖尿病(T1DM)合并肾病患者的血压和夜间血压下降模式正常化。然而,在这些患者中,关于双重阻断对夜间血压下降模式影响的数据尚不多见。因此,我们开展了本项研究,以评估在 T1DM 合并肾病患者中,以最佳剂量给予 ACEI 后继以 ARB 对 24 小时血压(BP)谱和夜间血压下降模式的影响。

方法

这是一项为期一年的开放标签干预性试点研究,共纳入 30 例连续患者,这些患者首先接受替米沙坦 80mg(0800-1000 时)治疗 8 周,然后在接下来的 8 周内加用雷米普利 10mg(1200-1400 时)。在每个阶段后均检测动态血压、夜间血压下降模式和白蛋白排泄率。20 例患者为高血压,10 例患者有大量白蛋白尿,20 例患者有微量白蛋白尿。

结果

替米沙坦使诊室血压降低 4/1.3mmHg(P<0.05 和 P<0.362),24 小时平均血压降低 2/1.9mmHg,白天血压降低 1.4/1.1mmHg,夜间血压降低 3.7/3mmHg。替米沙坦加用雷米普利后,诊室血压进一步降低 6.3/5.9mmHg(均 P<0.001),24 小时平均血压降低 4.3/4.2mmHg(均 P<0.01 和 P<0.0001),白天血压降低 5.8/3.9mmHg(均 P<0.01),夜间血压降低 4.2/2.5mmHg,与基线相比,诊室收缩压和舒张压分别降低 10.3/7.2mmHg。替米沙坦使 33.3%的夜间血压未下降者的收缩压夜间下降模式恢复正常(P<0.01),但加用雷米普利后并未产生互补作用。仅在研究结束时 2 例患者观察到血钾升高(>5.5mmol/L)。

结论和解释

替米沙坦和雷米普利的双重阻断对降低血压具有互补作用,但对夜间血压下降模式没有观察到类似的有益作用。需要进行更多的研究,纳入更多的对象,并进行更长时间的随访,以验证这些观察结果。

相似文献

9
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Lancet. 2017 Jun 3;389(10085):2226-2237. doi: 10.1016/S0140-6736(17)30754-7. Epub 2017 Apr 5.

引用本文的文献

1
Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis.
Diabetes Ther. 2019 Feb;10(1):229-243. doi: 10.1007/s13300-018-0551-9. Epub 2019 Jan 7.

本文引用的文献

2
Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
4
Standards of medical care in diabetes--2008.
Diabetes Care. 2008 Jan;31 Suppl 1:S12-54. doi: 10.2337/dc08-S012.
6
Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.
Circulation. 2007 Apr 24;115(16):2145-52. doi: 10.1161/CIRCULATIONAHA.106.662254. Epub 2007 Apr 9.
7
Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
Diabet Med. 2007 May;24(5):486-93. doi: 10.1111/j.1464-5491.2007.02097.x. Epub 2007 Mar 15.
8
Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity.
Hypertension. 2006 Oct;48(4):527-33. doi: 10.1161/01.HYP.0000240268.37379.7c. Epub 2006 Aug 28.
9
Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate.
Arch Intern Med. 2006 Apr 24;166(8):846-52. doi: 10.1001/archinte.166.8.846.
10
Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study.
Am J Hypertens. 2006 Mar;19(3):243-50. doi: 10.1016/j.amjhyper.2005.09.018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验